Avadel Pharmaceuticals (AVDL) Leases (2017 - 2022)
Historic Leases for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Q3 2022 value amounting to $1.9 million.
- Avadel Pharmaceuticals' Leases fell 594.2% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year decrease of 594.2%. This contributed to the annual value of $2.7 million for FY2021, which is 184.33% up from last year.
- Avadel Pharmaceuticals' Leases amounted to $1.9 million in Q3 2022, which was down 594.2% from $2.2 million recorded in Q2 2022.
- Avadel Pharmaceuticals' 5-year Leases high stood at $6.0 million for Q3 2018, and its period low was $1.9 million during Q3 2022.
- For the 5-year period, Avadel Pharmaceuticals' Leases averaged around $3.5 million, with its median value being $3.0 million (2020).
- Its Leases has fluctuated over the past 5 years, first surged by 7346.17% in 2018, then tumbled by 4284.93% in 2020.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Leases stood at $5.0 million in 2018, then fell by 28.42% to $3.6 million in 2019, then dropped by 27.91% to $2.6 million in 2020, then rose by 1.84% to $2.7 million in 2021, then decreased by 26.58% to $1.9 million in 2022.
- Its last three reported values are $1.9 million in Q3 2022, $2.2 million for Q2 2022, and $2.4 million during Q1 2022.